Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model

Cardiovasc Res. 2003 Aug 1;59(2):501-11. doi: 10.1016/s0008-6363(03)00390-0.

Abstract

Objective: Endothelium-dependent G-protein mediated relaxations of epicardial coronary arteries is impaired with left ventricular hypertrophy. The objective of this study was to assess the effect of L-arginine, BH(4) and the combination of two antioxidants, superoxide dismutase and catalase, on endothelium-dependent relaxations in a swine left ventricular hypertrophy model.

Methods: Aortic banding was performed 3 cm above the coronary ostia. Vascular reactivity studies were performed in standard organ chamber experiments to assess the NO pathway in the presence of methyltetrahydropterin (a BH(4) analogue), L-arginine, superoxide dismutase and catalase.

Results: There was a statistically significant increase in endothelium-dependent relaxation to serotonin and to bradykinin with methyltetrahydropterin and with superoxide dismutase plus catalase (P<0.05) but not with L-arginine compared to untreated coronary arteries from left ventricular hypertrophy animals. Plasma 3-nitrotyrosine level increased significantly from 918+/-122 to 1844+/-300 microM (P<0.05 vs. control) after 60 days of aortic banding. Endothelial dysfunction was not associated with a reduced expression of endothelial nitric oxide synthase 2 months after pressure overload left ventricular hypertrophy.

Conclusions: Treatment with BH(4) and antioxidants constitutes an interesting approach for the prevention of endothelial dysfunction in epicardial coronary arteries associated with left ventricular hypertrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Arginine / pharmacology
  • Biomarkers / blood
  • Bradykinin / pharmacology
  • Catalase / pharmacology
  • Coronary Vessels*
  • Dose-Response Relationship, Drug
  • Echocardiography
  • Endothelium, Vascular / drug effects*
  • Female
  • Hemodynamics
  • Hypertrophy, Left Ventricular / blood
  • Hypertrophy, Left Ventricular / physiopathology*
  • In Vitro Techniques
  • Ketanserin / pharmacology
  • Male
  • Models, Animal
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III
  • Oxidative Stress
  • Peroxynitrous Acid / blood
  • Pterins / pharmacology*
  • Serotonin / pharmacology
  • Serotonin Antagonists / pharmacology
  • Superoxide Dismutase / pharmacology
  • Swine
  • Tyrosine / analogs & derivatives*
  • Tyrosine / blood

Substances

  • Antioxidants
  • Biomarkers
  • Pterins
  • Serotonin Antagonists
  • Peroxynitrous Acid
  • Serotonin
  • 3-nitrotyrosine
  • Tyrosine
  • Arginine
  • Ketanserin
  • 6-methyltetrahydropterin
  • Catalase
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Superoxide Dismutase
  • Bradykinin